Home › NDC Lookup › RxCUI directory › RxCUI 1666332

Ticagrelor 60 MG Oral Tablet — RxCUI 1666332

RxNorm drug concept · Semantic clinical drug
RxCUI 1666332 Semantic clinical drug · SCD ● Current RxNorm concept 39 FDA products 82 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1666332
Official nameTicagrelor 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped39
Package NDCs mapped82
Reported Medicaid activity (SDUD)178,017 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ticagrelor: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Because of how quickly your body clears ticagrelor — its half-life is only about 7 hours — twice-daily dosing is needed to keep enough of the drug in your system to protect you aro...
  • Why do I have to take ticagrelor twice a day — can I just take it once?
  • Shortness of breath is actually one of the more common side effects of ticagrelor — roughly 1 in 7 people experience it. The good news is it's usually mild to moderate, it doesn't...
  • I've been feeling short of breath since I started ticagrelor. Should I be worried?
📖 Read our full Ticagrelor guide →

🕸️ Concept Web — How Ticagrelor 60 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ticagrelor 60 MG Oral Tablet RxCUI 1666332

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ticagrelor 1116632
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Brilinta 1116636
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ticagrelor Oral Tablet 1116634
    • Ticagrelor Oral Product 1157089
    • Ticagrelor Pill 1157090
    • Ticagrelor Oral Tablet [Brilinta] 1116638
    • Brilinta Oral Product 1176340
    • Brilinta Pill 1176341
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ticagrelor 60 MG SCDC · 1666331
  • Ticagrelor Oral Tablet SCDF · 1116634
  • Ticagrelor Oral Product SCDG · 1157089
  • Ticagrelor Pill SCDG · 1157090

Brand-Name Concepts

  • Ticagrelor 60 MG Oral Tablet [Brilinta] SBD · 1666334
  • Ticagrelor 60 MG [Brilinta] SBDC · 1666333
  • Ticagrelor Oral Tablet [Brilinta] SBDF · 1116638
  • Brilinta Oral Product SBDG · 1176340
  • Brilinta Pill SBDG · 1176341
  • Brilinta BN · 1116636

📦 FDA Products & Package NDCs

39 products · 82 package NDCs
82 package NDCs map to RxCUI 1666332 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00186-0776-60 60 TABLET in 1 BOTTLE (0186-0776-60) BRILINTA AstraZeneca Pharmaceuticals LP 2015-09-04
00186-0777-39 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0186-0777-39) / 10 TAB... BRILINTA AstraZeneca Pharmaceuticals LP 2011-08-05
00186-0777-60 60 TABLET in 1 BOTTLE (0186-0777-60) BRILINTA AstraZeneca Pharmaceuticals LP 2011-08-05
00378-2214-91 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2214-91) Ticagrelor Mylan Pharmaceuticals Inc. 2025-09-25
00378-2215-91 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2215-91) Ticagrelor Mylan Pharmaceuticals Inc. 2025-09-25
00480-2688-06 60 TABLET, FILM COATED in 1 BOTTLE (0480-2688-06) Ticagrelor Teva Pharmaceuticals, Inc. 2025-05-01
00480-2695-06 60 TABLET, FILM COATED in 1 BOTTLE (0480-2695-06) Ticagrelor Teva Pharmaceuticals, Inc. 2025-05-01
11788-0157-60 60 TABLET in 1 BOTTLE (11788-157-60) Ticagrelor AiPing Pharmaceutical, Inc 2026-06-10
11788-0158-01 100 TABLET in 1 BOTTLE (11788-158-01) Ticagrelor AiPing Pharmaceutical, Inc 2026-06-10
11788-0158-60 60 TABLET in 1 BOTTLE (11788-158-60) Ticagrelor AiPing Pharmaceutical, Inc 2026-06-10
33342-0431-09 60 TABLET, FILM COATED in 1 BOTTLE (33342-431-09) Ticagrelor Macleods Pharmaceuticals Limited 2025-10-28
33342-0431-12 10 BLISTER PACK in 1 CARTON (33342-431-12) / 10 TABLET, FIL... Ticagrelor Macleods Pharmaceuticals Limited 2025-10-28
33342-0432-09 60 TABLET, FILM COATED in 1 BOTTLE (33342-432-09) Ticagrelor Macleods Pharmaceuticals Limited 2025-10-28
33342-0432-12 10 BLISTER PACK in 1 CARTON (33342-432-12) / 10 TABLET, FIL... Ticagrelor Macleods Pharmaceuticals Limited 2025-10-28
43598-0480-18 180 TABLET in 1 BOTTLE (43598-480-18) Ticagrelor Dr. Reddys Laboratories Inc 2025-04-30
43598-0480-60 60 TABLET in 1 BOTTLE (43598-480-60) Ticagrelor Dr. Reddys Laboratories Inc 2025-04-30
43598-0480-78 10 BLISTER PACK in 1 CARTON (43598-480-78) / 10 TABLET in 1... Ticagrelor Dr. Reddys Laboratories Inc 2025-04-30
43598-0480-79 1 BLISTER PACK in 1 CARTON (43598-480-79) / 10 TABLET in 1... Ticagrelor Dr. Reddys Laboratories Inc 2025-04-30
43598-0629-18 180 TABLET in 1 BOTTLE (43598-629-18) Ticagrelor Dr. Reddys Laboratories Inc 2025-10-28
43598-0629-60 60 TABLET in 1 BOTTLE (43598-629-60) Ticagrelor Dr. Reddys Laboratories Inc 2025-10-28
46708-0241-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-241-30) Ticagrelor Alembic Pharmaceuticals Limited 2025-05-01
46708-0241-31 100 TABLET, FILM COATED in 1 BOTTLE (46708-241-31) Ticagrelor Alembic Pharmaceuticals Limited 2025-05-01
46708-0241-60 60 TABLET, FILM COATED in 1 BOTTLE (46708-241-60) Ticagrelor Alembic Pharmaceuticals Limited 2025-05-01
46708-0241-91 1000 TABLET, FILM COATED in 1 BOTTLE (46708-241-91) Ticagrelor Alembic Pharmaceuticals Limited 2025-05-01
46708-0500-60 60 TABLET, FILM COATED in 1 BOTTLE (46708-500-60) Ticagrelor Alembic Pharmaceuticals Limited 2025-10-28
46708-0500-71 500 TABLET, FILM COATED in 1 BOTTLE (46708-500-71) Ticagrelor Alembic Pharmaceuticals Limited 2025-10-28
50228-0521-10 1000 TABLET in 1 BOTTLE (50228-521-10) ticagrelor ScieGen Pharmaceuticals INC 2025-10-09
50228-0521-30 30 TABLET in 1 BOTTLE (50228-521-30) ticagrelor ScieGen Pharmaceuticals INC 2025-10-09
50228-0521-60 60 TABLET in 1 BOTTLE (50228-521-60) ticagrelor ScieGen Pharmaceuticals INC 2025-10-09
50228-0522-10 1000 TABLET in 1 BOTTLE (50228-522-10) ticagrelor ScieGen Pharmaceuticals INC 2025-10-09
50228-0522-30 30 TABLET in 1 BOTTLE (50228-522-30) ticagrelor ScieGen Pharmaceuticals INC 2025-10-09
50228-0522-60 60 TABLET in 1 BOTTLE (50228-522-60) ticagrelor ScieGen Pharmaceuticals INC 2025-10-09
55488-0543-01 60 TABLET in 1 BOTTLE (55488-0543-1) Ticagrelor Changzhou Pharmaceutical Factory 2025-10-28
55488-0543-02 500 TABLET in 1 BOTTLE (55488-0543-2) Ticagrelor Changzhou Pharmaceutical Factory 2025-10-28
55488-0544-01 60 TABLET in 1 BOTTLE (55488-0544-1) Ticagrelor Changzhou Pharmaceutical Factory 2025-10-28
55488-0544-02 500 TABLET in 1 BOTTLE (55488-0544-2) Ticagrelor Changzhou Pharmaceutical Factory 2025-10-28
60505-4452-06 60 TABLET in 1 BOTTLE (60505-4452-6) Ticagrelor Apotex Corp. 2025-05-01
60505-4453-06 60 TABLET in 1 BOTTLE (60505-4453-6) Ticagrelor Apotex Corp. 2025-10-31
60687-0928-57 60 BLISTER PACK in 1 CARTON (60687-928-57) / 1 TABLET in 1... Ticagrelor American Health Packaging 2025-12-01
60687-0935-21 30 BLISTER PACK in 1 CARTON (60687-935-21) / 1 TABLET in 1... Ticagrelor American Health Packaging 2026-01-04
62332-0241-30 30 TABLET, FILM COATED in 1 BOTTLE (62332-241-30) Ticagrelor Alembic Pharmaceuticals Inc. 2025-05-01
62332-0241-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-241-31) Ticagrelor Alembic Pharmaceuticals Inc. 2025-05-01
62332-0241-60 60 TABLET, FILM COATED in 1 BOTTLE (62332-241-60) Ticagrelor Alembic Pharmaceuticals Inc. 2025-05-01
62332-0241-91 1000 TABLET, FILM COATED in 1 BOTTLE (62332-241-91) Ticagrelor Alembic Pharmaceuticals Inc. 2025-05-01
62332-0500-60 60 TABLET, FILM COATED in 1 BOTTLE (62332-500-60) Ticagrelor Alembic Pharmaceuticals Inc. 2025-10-28
62332-0500-71 500 TABLET, FILM COATED in 1 BOTTLE (62332-500-71) Ticagrelor Alembic Pharmaceuticals Inc. 2025-10-28
67877-0522-05 500 TABLET, FILM COATED in 1 BOTTLE (67877-522-05) Ticagrelor Ascend Laboratories, LLC 2025-10-28
67877-0522-14 14 TABLET, FILM COATED in 1 BOTTLE (67877-522-14) Ticagrelor Ascend Laboratories, LLC 2025-10-28
67877-0522-18 180 TABLET, FILM COATED in 1 BOTTLE (67877-522-18) Ticagrelor Ascend Laboratories, LLC 2025-10-28
67877-0522-38 10 BLISTER PACK in 1 CARTON (67877-522-38) / 10 TABLET, FIL... Ticagrelor Ascend Laboratories, LLC 2025-10-28
Observed labelers: Novadoz Pharmaceuticals LLC (8) · Alembic Pharmaceuticals Inc. (6) · Alembic Pharmaceuticals Limited (6) · Cipla USA Inc. (6) · Dr. Reddys Laboratories Inc (6) · Exelan Pharmaceuticals, Inc (6) · +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.